Navigation Links
Environmentally friendly chemistry important for manufacturing pharmaceuticals
Date:11/8/2012

Limiting the quantity of catalysts substances that trigger a chemical reaction used in the manufacture of pharmaceuticals is important, and research from the University of Gothenburg, Sweden, has now demonstrated that small quantities of copper work well in this respect.

"This is an important finding, not just academically but also for industry," says chemist Per-Fredrik Larsson.

Catalysis is an incredibly valuable tool in the field of chemistry, with the Haber-Bosch process being one of the most important catalytic processes in the world. It is used to manufacture fertilizer, and calculations show that without it the world's population would be just half of what it is today.

Precious metals are often used as catalysts in organic chemistry as they enable the production of many organic molecules with applications in areas such as pharmaceuticals and fine chemicals. As recently as 2010 Richard F. Heck, Ei-ichi Negishi and Akira Suzuki were awarded the Nobel Prize in Chemistry for their work on palladium catalysis.

"A problem with precious metals like palladium is that they are both expensive and harmful to the environment," says Per-Fredrik Larsson at the Department of Chemistry and Molecular Biology.

Recent years have seen researchers evaluating several different non-precious metals primarily iron and copper as cheap and environmentally friendly alternatives to precious metals.

"Iron catalysts have proven to be a competitive alternative to precious metals for a number of reactions," says Per-Fredrik Larsson. "An in-depth understanding of how these reactions work is incredibly important if we are to take this further. The results from our studies with iron led to several important insights into just how complex the chemistry can be."

Larsson's research group works not only with experimental methods but also with calculation models to understand how the chemistry works.

The trend for swapping precious metals for non-precious alternatives also has a flipside. It was discovered during experiments with iron catalysis in conjunction with professor Carsten Bolm of RWTH Aachen University in Germany that some reactions thought to be catalysed by iron had actually been catalysed by traces of copper in the commercially available iron source.

The fact that traces of copper could catalyse a number of different reactions was surprising as copper had previously been thought to be an ineffective catalyst requiring large quantities and high reaction temperatures.

"Our results show that copper has been given an undeservedly bad name as a catalyst," says Per-Fredrik Larsson. "Given that copper chemistry is over a century old, it's surprising that nobody's realised this before."

It is important in the pharmaceutical industry to limit the use of catalysts as the quantity of metal in the end-product is strictly regulated and the recovery process can be both difficult and expensive. As such, the finding that small quantities of copper can be used is an important discovery.

"We've developed and studied reactions with small quantities of copper and tried to understand how and why they work," says Per-Fredrik Larsson.

The results and conclusions for iron and copper catalysts are a major contribution to this field of research and are important for its continued development.


'/>"/>
Contact: Per-Fredrik Larsson
per-fredrik.larsson@chem.gu.se
46-031-786-9104
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. Nanoparticles detect biochemistry of inflammation
2. UGA chemistry discovery could have major medical implications
3. Heroes of Chemistry: Developed new drugs and technology to cut heating and cooling bills
4. Government can play important role in obesity epidemic
5. Cancer turns off important immune cells, complicating experimental vaccine therapies
6. Timing of antibiotics important in reducing infections after C-section
7. An important breakthrough in immunology by IRCM researchers
8. Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery
9. Joslin scientists identify important mechanism that affects the aging process
10. Moffitt Cancer Center researchers: Quality of life as important as quantity of life
11. Timing pregnancy an important health concern for women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: